BEAM THERAPEUTICS INC (BEAM) — insider trading
Health Care · NASDAQ
BEAM THERAPEUTICS INC (BEAM) has 31 reported SEC Form 4 insider transactions in our data, including 14 open-market sales among the most recent 31 (latest 2026-10-01).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Cavanagh Bethany J | Officer (SVP, Finance and Treasurer) | Open-market sale | 187 | $24.41 | $4.6K | Form 4 |
| 2026-09-24 | Ciaramella Giuseppe | Officer (President) | Bona fide gift | 123,407 | — | $0 | Form 4 |
| 2026-07-27 | Simon Amy | Officer (Chief Medical Officer) | Open-market sale | 16,667 | $25.74 | $429.0K | Form 4 |
| 2026-06-30 | Simon Amy | Officer (Chief Medical Officer) | Open-market sale | 373 | $34.73 | $13.0K | Form 4 |
| 2026-06-30 | Evans John M. | Director, Officer (CEO) | Option exercise / conversion (derivative) | 25,000 | — | $0 | Form 4 |
| 2026-06-30 | Evans John M. | Director, Officer (CEO) | Open-market sale | 1,900 | $34.84 | $66.2K | Form 4 |
| 2026-06-30 | Evans John M. | Director, Officer (CEO) | Open-market sale | 23,100 | $34.26 | $791.5K | Form 4 |
| 2026-06-30 | Evans John M. | Director, Officer (CEO) | Option exercise / conversion | 25,000 | $1.03 | $25.8K | Form 4 |
| 2026-06-29 | Evans John M. | Director, Officer (CEO) | Option exercise / conversion (derivative) | 6,337 | — | $0 | Form 4 |
| 2026-06-29 | Evans John M. | Director, Officer (CEO) | Option exercise / conversion (derivative) | 18,663 | — | $0 | Form 4 |
| 2026-06-29 | Evans John M. | Director, Officer (CEO) | Open-market sale | 11,579 | $35.91 | $415.8K | Form 4 |
| 2026-06-29 | Evans John M. | Director, Officer (CEO) | Open-market sale | 13,421 | $35.13 | $471.5K | Form 4 |
| 2026-06-29 | Evans John M. | Director, Officer (CEO) | Option exercise / conversion | 6,337 | $1.03 | $6.5K | Form 4 |
| 2026-06-29 | Evans John M. | Director, Officer (CEO) | Option exercise / conversion | 18,663 | $0.67 | $12.5K | Form 4 |
| 2026-06-26 | FMR LLC | 10% owner, Other | Open-market sale | 251,488 | $35.26 | $8.87M | Form 4 |
| 2026-06-25 | FMR LLC | 10% owner, Other | Open-market sale | 33,372 | $35.12 | $1.17M | Form 4 |
| 2026-06-17 | Ciaramella Giuseppe | Officer (President) | Option exercise / conversion (derivative) | 29,000 | — | $0 | Form 4 |
| 2026-06-17 | Ciaramella Giuseppe | Officer (President) | Option exercise / conversion (derivative) | 6,505 | — | $0 | Form 4 |
| 2026-06-17 | Ciaramella Giuseppe | Officer (President) | Option exercise / conversion | 29,000 | $1.03 | $29.9K | Form 4 |
| 2026-06-17 | Ciaramella Giuseppe | Officer (President) | Option exercise / conversion | 6,505 | $0.67 | $4.4K | Form 4 |
| 2026-06-03 | COOPER GRAHAM K | Director | Grant / award / vesting (derivative) | 19,676 | — | $0 | Form 4 |
| 2026-06-03 | Guindo Chirfi | Director | Grant / award / vesting (derivative) | 19,676 | — | $0 | Form 4 |
| 2026-06-03 | Fishman Mark | Director | Grant / award / vesting (derivative) | 19,676 | — | $0 | Form 4 |
| 2026-06-03 | MARAGANORE JOHN | Director | Grant / award / vesting (derivative) | 19,676 | — | $0 | Form 4 |
| 2026-06-03 | Walsh Kathleen E | Director | Grant / award / vesting (derivative) | 19,676 | — | $0 | Form 4 |
| 2026-06-03 | Shaw Christi | Director | Grant / award / vesting (derivative) | 19,676 | — | $0 | Form 4 |
| 2026-04-01 | Ciaramella Giuseppe | Officer (President) | Open-market sale | 11,810 | $24.58 | $290.3K | Form 4 |
| 2026-04-01 | Bellon Christine | Officer (Chief Legal Officer) | Open-market sale | 5,956 | $24.58 | $146.4K | Form 4 |
| 2026-04-01 | Cavanagh Bethany J | Officer (SVP, Finance and Treasurer) | Open-market sale | 3,242 | $24.58 | $79.7K | Form 4 |
| 2026-04-01 | Simon Amy | Officer (Chief Medical Officer) | Open-market sale | 6,700 | $24.58 | $164.7K | Form 4 |
| 2026-04-01 | Evans John M. | Director, Officer (CEO) | Open-market sale | 30,078 | $24.58 | $739.3K | Form 4 |
Ask the chat about BEAM's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: BEAM THERAPEUTICS INC (BEAM).
Last updated 2026-10-01 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.